نتائج البحث

A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers

• Source: A Phase 1, Open-label Study of Oral BDTX-4933 in Patients With KRAS, BRAF and Other Select RAS/MAPK Mutation Positive Neoplasms

تفاصيل العنوان

Novel BRAF N581S mutation in mantle cell lymphoma.

• Authors : Bedi, Davsheen; Choi, Michael; Wang, Huan-You

Subjects: BRAF mutation; mantle cell lymphoma; novel

• Source: ejHaem. 5(1)

تفاصيل العنوان

Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review.

• Authors : Yu, Nina; Raslan, Osama; Lee, Han

Subjects: BRAF inhibitors; BRAF mutation; MEK inhibitors

• Source: CNS Oncology. 13(1)

تفاصيل العنوان

Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion–insertion R) in an advanced non‐small cell lung cancer patient

• Authors : Akiko Tamura; Ryoko Inaba Higashiyama; Tatsuya Yoshida

Subjects: BRAF mutation; BRAF V600_W604 deletion–insertion R; comprehensive genomic profiling

• Source: Thoracic Cancer, Vol 15, Iss 18, Pp 1454-1456 (2024)

تفاصيل العنوان

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

• Authors : Lovisa Falkman; Anders Sundin; Britt Skogseid

Subjects: neuroendocrine carcinoma; neuroendocrine neoplasm; braf-mutation

• Source: Upsala Journal of Medical Sciences, Vol 129, Pp 1-7 (2024)

تفاصيل العنوان

Survival of Patients With Primary Cutaneous Melanoma (Stages 0-IIА and IIB-IIC), Depending on the Presence of the BRAF Mutation in the Tumor and Surgical Treatment Option

• Authors : S. A. Yаrgunin; I. V. Reshetov; Ya. N. Shoykhet

Subjects: cutaneous melanoma; braf mutation; surgical treatment

• Source: Инновационная медицина Кубани, Vol 0, Iss 1, Pp 8-17 (2024)

تفاصيل العنوان

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report

• Authors : Daniele Barbaro; Raffaella Forleo; Maria Antonietta Profilo

Subjects: anaplastic thyroid cancer; lenvatinib; pembrolizumab

• Source: Frontiers in Endocrinology, Vol 15 (2024)

تفاصيل العنوان

The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells

• Authors : Yulu Chen; Ye Sang; Shiyong Li

Subjects: BRAF mutation; ERK inhibitor; Cell cycle

• Source: Translational Oncology, Vol 45, Iss , Pp 101991- (2024)

تفاصيل العنوان

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

• Source: A Pilot Study of the Addition of Cemiplimab, an Antibody to PD-1, to the Treatment of Subjects With BRAF-Mutant Anaplastic Thyroid Cancer Who Are No Longer Responding to

تفاصيل العنوان

Incidental Langerhans cell histiocytosis associated with metastatic neuroendocrine tumor in the adult liver

• Authors : Joseph, Nancy M; Wen, Kwun Wah

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Cancer

• Source: Clinical Case Reports. 11(2)

تفاصيل العنوان